Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02627079 · ClinicalTrials.gov registry record · NA
ICanSTEP : Increasing Physical Activity With Text Messaging
A NA study of A Diagnosis of Any Hematologic or Solid Malignancy, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02627079: Completed NA study of A Diagnosis of Any Hematologic or Solid Malignancy, sponsored by Duke University.
NCT02627079 is a NA study of A Diagnosis of Any Hematologic or Solid Malignancy that has completed, run by Duke University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02627079, a NA study of A Diagnosis of Any Hematologic or Solid Malignancy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot study will develop and test feasibility and preliminary efficacy of an exercise motivation intervention using a 12-week smartphone-text messaging program tailored to physical activity data retrieved from a Fitbit. Target population is 15 cancer survivors and 15 patients actively undergoing cancer treatment.
Conditions Studied
Interventions
- OTHER Daily SMS text messaging
Study Locations (1)
North Carolina
- Duke Cancer Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-08-04 |
| Est. Completion | 2018-05-21 |
| Phase | NA |
What the finished NCT02627079 record still lists
NCT02627079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with A Diagnosis of Any Hematologic or Solid Malignancy appearing as the primary indexed condition, and to 1 intervention - of which Daily SMS text messaging is the first listed.
NCT02627079 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02627079 about?
NCT02627079 is a clinical study titled "ICanSTEP : Increasing Physical Activity With Text Messaging". The proposed pilot study will develop and test feasibility and preliminary efficacy of an exercise motivation intervention using a 12-week smartphone-text messaging program tailored to physical activity data retrieved from a Fitbit. Target population is 15 cancer survivors and 15 patients actively u...
What is the current status of trial NCT02627079?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-08-04. Estimated completion is 2018-05-21.
What conditions does trial NCT02627079 study?
This clinical trial studies the following conditions: A Diagnosis of Any Hematologic or Solid Malignancy.
What interventions are being tested in trial NCT02627079?
The interventions under investigation include: Daily SMS text messaging (OTHER).
Who is sponsoring clinical trial NCT02627079?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02627079 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02627079's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI